New hemolysin (gamma) produced by Escherichia coli.
A new hemolysin (gamma) of Escherichia coli, active in the absence of viable bacteria, has been recognized in mutants resistant to nalidixic acid. Nalidixic acid affects either the production or release of the hemolysin.
D000818:Animals; D004352:Drug Resistance, Microbial; D004912:Erythrocytes / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects / Q000378:metabolism*; D006168:Guinea Pigs; D006460:Hemolysin Proteins / Q000096:biosynthesis* / Q000494:pharmacology; D006736:Horses; D006801:Humans; D009154:Mutation; D009268:Nalidixic Acid / Q000494:pharmacology; D011817:Rabbits; D012756:Sheep
D006460:Hemolysin Proteins; D009268:Nalidixic Acid